OptimizeRx Corp OPRX
OptimizeRx Corp (OPRX) earns a Piotroski F-score of 8/9 (strong financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $109.4M at a 4.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.84 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.246 |
| Retained earnings / assets | -0.448 |
| EBIT / assets | 0.066 |
| Equity / liabilities | 2.638 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | 8/9 | 3.37 | 18.7 | +18.8% |
| BAER | Bridger Aerospace Group Holdings, Inc. | 7/9 | — | 24.1 | +24.6% |
| NOTE | FiscalNote Holdings, Inc. | 2/9 | -12.08 | — | -20.7% |
| DHX | DHI GROUP, INC. | 4/9 | -0.09 | — | -9.9% |
| SGRP | SPAR Group, Inc. | 2/9 | -4.77 | — | -16.8% |
| PAYS | Paysign, Inc. | 6/9 | 1.14 | 60.5 | +40.5% |
| POWW | Outdoor Holding Co | 7/9 | 6.36 | — | +3.5% |
About OptimizeRx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
FAQ
Is OPRX financially healthy?
OptimizeRx Corp's Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does OPRX pay a dividend?
No, OptimizeRx Corp does not currently pay a dividend.
How profitable is OPRX?
In FY2025, OptimizeRx Corp had a net margin of 4.7% and a return on equity of 4.0%.
What is OPRX's P/E ratio?
OptimizeRx Corp's trailing price-to-earnings (P/E) ratio is about 18.7×, based on its latest annual earnings.
What is the analyst price target for OPRX?
The average Wall-Street price target for OptimizeRx Corp is $12.40, about 76.1% above the recent price, from 5 analysts (consensus: strong buy).
Is OPRX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on OptimizeRx Corp: a Piotroski F-score of 8/9, an Altman Z″ in the safe zone, a P/E of about 18.7×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.